Sang Byung Bae

Sang Byung Bae

Auto-generated profile, based on publicly available information

Sang Byung Bae

Department of Internal Medicine, Soonchunhyang University Cheonan Hospital, Cheonan, Korea

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2010 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
HKHyun Jung Kim
Hyun Jung Kim
JYJina Yun
Jina Yun
HKHan Jo Kim
Han Jo Kim
KKKyoung Ha Kim
Kyoung Ha Kim
SKSe Hyung Kim
Se Hyung Kim
DHDae Sik Hong
Dae Sik Hong
Kim HJ, et al. J Korean Med Sci. 2010 Dec;25(12):1748-1753. http://dx.doi.org/10.3346/jkms.2010.25.12.1748

1 January 2012 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
HKHyun Jung Kim
Hyun Jung Kim
HKHan Jo Kim
Han Jo Kim
JYJina Yun
Jina Yun
KKKyoung Ha Kim
Kyoung Ha Kim
SKSe Hyung Kim
Se Hyung Kim
DHDae Sik Hong
Dae Sik Hong
Kim HJ, et al. J Korean Med Sci. 2012 Feb;27(2):128-134. http://dx.doi.org/10.3346/jkms.2012.27.2.128

1 January 2016 in Journal of Breast Cancer
Verified
Journal Article
Open access
PDF file
SJSi-Hyong Jang
Si-Hyong Jang
JLJong Eun Lee
Jong Eun Lee
MOMee-Hye Oh
Mee-Hye Oh
JLJi-Hye Lee
Ji-Hye Lee
HCHyun Deuk Cho
Hyun Deuk Cho
HLHyun Ju Lee
Hyun Ju Lee
Jang SH, et al. J Breast Cancer. 2016 Mar;19(1):53-60. https://doi.org/10.4048/jbc.2016.19.1.53

1 December 2011 in Cancer Research and Treatment
Verified
Journal Article
Open access
PDF file
JKJi Yeon Kwon
Ji Yeon Kwon
JYJina Yun
Jina Yun
HKHan Jo Kim
Han Jo Kim
KKKyoung-Ha Kim
Kyoung-Ha Kim
SKSe-Hyung Kim
Se-Hyung Kim
HPHee Sook Park
Hee Sook Park
Kwon JY, et al. Cancer Res Treat. 2011 Dec;43(4):244-249. http://dx.doi.org/10.4143/crt.2011.43.4.244

1 May 2006 in International Journal of Hematology
Verified
Journal Article
Closed access
PDF file
JWJong-Ho Won
Jong-Ho Won
SHSeung-Hyo Han
Seung-Hyo Han
SBSang-Byung Bae
Sang-Byung Bae
CKChan Kyu Kim
Chan Kyu Kim
NLNam-Su Lee
Nam-Su Lee
HPHee-Sook Park
Hee-Sook Park
Primary effusion lymphoma (PEL) is a recently recognized disease that occurs most often in immunosuppressed patients, either with human immunodeficiency virus (HIV) or in the posttransplantation setting, and it occasionally occurs in nonim-munosuppressed patients. Patients present with lymphomatous effusions in serous cavities—pleura, pericardium, or peritoneum–without any identifiable tumor mass. PEL rarely responds to systemic chemotherapy, and the prognosis is poor, with a median survival time of less than 6 months for most cohorts. A standard treatment for PEL has not yet been identified. We describe a patient with HIV-seronegative PEL who relapsed after combination chemotherapy and then underwent successful treatment with high-dose chemotherapy (HDC) and autologous stem cell transplantation (ASCT).The treatment was well tolerated, and the patient has been in remission for 12 months after HDC and ASCT.

8 December 2015 in International Journal of Oncology
Verified
Journal Article
Closed access
DJDongjun Jeong
Dongjun Jeong
SPSoyoung Park
Soyoung Park
HKHyungjoo Kim
Hyungjoo Kim
CKChang-Jin Kim
Chang-Jin Kim
TATae Sung Ahn
Tae Sung Ahn
MBMoo Jun Baek
Moo Jun Baek
Spandidos Publications is a scientific publisher with a long-standing international reputation for excellent standards and high quality science publications